Clinical Trials in Anyang, South Korea
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Type 2 DiabetesDyslipidemia
CMG Pharmaceutical Co. Ltd240 enrolled24 locationsNCT06772168
Recruiting
Phase 2
Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-squamous Non-small Cell Lung Cancer
CrystalGenomics, Inc.60 enrolled8 locationsNCT05841472